Stock PCVX VAXCYTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Vaxcyte, Inc.

Equities

PCVX

US92243G1085

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
70.97 USD -2.12% Intraday chart for Vaxcyte, Inc. +1.00% +13.01%
May. 22 Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing MT
May. 14 Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM

Evolution of the average Target Price on Vaxcyte, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1e9ddd7c591.Sp1VBAR0QZ8BQl1DmFNNhthoD2_w1JBqZPNgOkdCKxI.ctIbZUIWNe9pNikm0WQd6u0gdwilgL0QF8oCSTQgTCsT-WBxXAw4_HEGKg~889ff8a204c0d2a2e94b56562ebe7aa1

Analyst Recommendations on Vaxcyte, Inc.

Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing MT
Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing MT
Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing MT
Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating MT
Needham Raises Price Target on Vaxcyte to $95 From $73, Maintains Buy Rating MT
Mizuho Initiates Vaxcyte With Buy Rating, Price Target is $69 MT
TD Cowen Starts Vaxcyte at Outperform MT
BofA Securities Adjusts Price Target on Vaxcyte to $68 From $63, Keeps Buy Rating MT
Guggenheim Adjusts Price Target on Vaxcyte to $65 From $66, Maintains Buy Rating MT
Needham Adjusts Price Target on Vaxcyte to $58 From $52, Maintains Buy Rating MT
SVB Securities Initiates Vaxcyte With Outperform Rating, Sets Price Target at $60 MT
Guggenheim Initiates Vaxcyte at Buy With $66 Price Target MT
BTIG Starts Vaxcyte at Buy With $69 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
70.97 USD
Average target price
103.1 USD
Spread / Average Target
+45.33%
High Price Target
113 USD
Spread / Highest target
+59.22%
Low Price Target
95 USD
Spread / Lowest Target
+33.86%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Vaxcyte, Inc.

Mizuho Securities
Needham & Co.
TD Cowen
BofA Securities
Guggenheim
SVB Securities LLC
BTIG

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PCVX Stock
  4. Consensus Vaxcyte, Inc.